NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT
Post# of 169
(Total Views: 105)
Posted On: 10/17/2024 5:02:09 PM
NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Appoints Robert Eno as New CEO to Lead Next Phase of Growth and Innovation
HeartBeam (NASDAQ: BEAT) has appointed Robert Eno as its new chief executive officer, effective Oct. 21, 2024. Eno, who joined the company as President in January 2023, will focus on guiding HeartBeam through FDA 510(k) clearance and preparing for commercialization of its transformative vector-based cardiac technology. Founder and current CEO, Dr. Branislav Vajdic, will transition to president, concentrating on advancing the company’s innovative technology and artificial intelligence applications. HeartBeam’s technology captures the heart’s electrical signals in three dimensions and aims to revolutionize cardiac care with a credit card-sized device capable of synthesizing a 12-lead ECG. With extensive experience in MedTech and strategic growth, Eno is expected to position the company for continued success.
NOTE TO INVESTORS: The latest news and updates relating to BEAT are available in the company’s newsroom at https://nnw.fm/BEAT
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
HeartBeam (NASDAQ: BEAT) has appointed Robert Eno as its new chief executive officer, effective Oct. 21, 2024. Eno, who joined the company as President in January 2023, will focus on guiding HeartBeam through FDA 510(k) clearance and preparing for commercialization of its transformative vector-based cardiac technology. Founder and current CEO, Dr. Branislav Vajdic, will transition to president, concentrating on advancing the company’s innovative technology and artificial intelligence applications. HeartBeam’s technology captures the heart’s electrical signals in three dimensions and aims to revolutionize cardiac care with a credit card-sized device capable of synthesizing a 12-lead ECG. With extensive experience in MedTech and strategic growth, Eno is expected to position the company for continued success.
NOTE TO INVESTORS: The latest news and updates relating to BEAT are available in the company’s newsroom at https://nnw.fm/BEAT
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
(0)
(0)